{"keywords": [{"value": "Theranos Inc", "rank": "1", "is_major": "N", "name": "organizations"}, {"value": "Holmes, Elizabeth (1984- )", "rank": "2", "is_major": "N", "name": "persons"}, {"value": "Tests (Medical)", "rank": "3", "is_major": "N", "name": "subject"}], "headline": {"kicker": "Breakingviews", "content_kicker": "Breakingviews", "main": "Theranos Under Fire"}, "byline": {"original": "By RICHARD BEALES", "person": [{"rank": 1, "role": "reported", "organization": "", "lastname": "BEALES", "firstname": "Richard"}]}, "web_url": "http://www.nytimes.com/2015/10/28/business/dealbook/theranos-under-fire.html", "source": "The New York Times", "subsection_name": "DealBook", "slideshow_credits": null, "type_of_material": "News", "_id": "562fea1d38f0d8595b45cab5", "multimedia": [], "pub_date": "2015-10-28T00:00:00Z", "print_page": null, "section_name": "Business Day", "word_count": "973", "blog": [], "news_desk": "Business", "snippet": "With questions raised about the blood-testing company\u2019s technology, its purported $9 billion valuation now looks overestimated.", "document_type": "article", "abstract": null, "lead_paragraph": "With questions raised about the blood-testing company\u2019s technology, its purported $9 billion valuation now looks overestimated."}